Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management

Irritable bowel syndrome (IBS) is a common disorder of gut–brain interaction (DGBI). IBS significantly impacts the quality of life of patients. Since its pathogenesis is unclear and can be multifactorial, it highlights the need for new and improved pharmaceutical drugs that not only improve bowel sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Herekar, Anam, Shimoga, Dhanush, Jehangir, Asad, Shahsavari, Dariush, Yan, Yun, Karunaratne, Tennekoon Buddhika, Sharma, Amol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257918/
https://www.ncbi.nlm.nih.gov/pubmed/37309470
http://dx.doi.org/10.2147/CEG.S384251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257918/
https://www.ncbi.nlm.nih.gov/pubmed/37309470
http://dx.doi.org/10.2147/CEG.S384251

Ejemplares similares